Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 13c
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Join SI Premium – FREE
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q3 EPS of ($0.79), $0.13 better than the analyst estimate of ($0.92).
For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wall Street's new pair trade: Long software, short chips
- Lesaka Technologies, Inc. (LSAK) PT Raised to $7.56 at Jefferies, 'A compelling fintech story'
- Flowserve names Brian Ezzell as CFO, effective October 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
